Intra-Cellular Ther Market Risk Adjusted Performance

ITCI
 Stock
  

USD 44.58  0.67  1.48%   

Intra-Cellular Ther market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Intra-Cellular Ther or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Intra-Cellular Ther has current Market Risk Adjusted Performance of (0.54).
MRAP 
 = 
ER[a] + (1/BETA - 1) 
ER[a] - RFR) 
 = 
(0.54)
ER[a] = Expected return on investing in Intra-Cellular Ther
RFR = Risk Free Rate of return. Typically T-Bill Rate
BETA = Beta of the asset with market or selected benchmark.

Intra-Cellular Market Risk Adjusted Performance Relative To Other Indicators

Intra-Cellular Ther is rated second overall in market risk adjusted performance category among related companies. It is currently under evaluation in maximum drawdown category among related companies .
Compare Intra-Cellular Ther to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas